Vimal Derebail

Associate Professor of Medicine

University of North Carolina at Chapel Hill

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vimal Derebail is an Associate Professor of Medicine at the University of North Carolina at Chapel Hill, USA. His research focuses on chronic kidney disease, sickle cell disease, and the renal implications of various medical treatments. Recent publications highlight his work on the intersection of sickle cell trait and kidney health, as well as innovations in the management of kidney diseases.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

View details

Eveline Wu

University of North Carolina

UNITED STATES

View details

Jessica Beers

Assistant Professor

University of Washington

UNITED STATES

View details

Seyed Mehdi Nouraie

Associate Professor

University of Pittsburgh

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vimal Derebail

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Chronic kidney disease in adults with sickle cell trait: a systematic review and meta-analysis

Antineutrophil Cytoplasmic Antibodies (ANCAs)

Protecting Individuals with Kidney Disease from Vaccine Preventable Infections

Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model

Altered bile acid and coproporphyrin‐I disposition in patients with autosomal dominant polycystic kidney disease

Emergency department intravenous fluid resuscitation and renal outcomes among adults with sickle cell disease

<scp>GLP</scp>‐1 agonists and <scp>SGLT</scp>‐2 inhibitors in adults with sickle cell disease

Persistent albuminuria and chronic kidney disease in adults with sickle cell anaemia: Results from a multicenter natural history study

Sparsentan and the Expanding Landscape of IgA Nephropathy Treatment

Emerging Therapies and Advances in Sickle Cell Disease with a Focus on Renal Manifestations

PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease

Prevalence and outcomes of dehydration in adults with sickle cell trait: the Atherosclerosis Risk in Communities (ARIC) study

The nephropathy of sickle cell trait and sickle cell disease

Hyperkalemia and Metabolic Acidosis Occur at Higher Estimated Glomerular Filtration Rates in Sickle Cell Disease

A glomerular transcriptomic landscape of apolipoprotein L1 in Black patients with focal segmental glomerulosclerosis

Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease

Should PLEX Be Used for Severe AKI and/or Pulmonary Hemorrhage in ANCA-Associated Vasculitis (AAV)? PRO

Treatment updates in Antineutrophil Cytoplasmic Autoantibodies (ANCA) vasculitis

Collaborators (10)

Enrico Novelli

Dorey Glenn

Koyal Jain

Nigel Key

John Charles Jennette

Steven Grover

Santosh L. Saraf

Eveline Wu

Jessica Beers

Seyed Mehdi Nouraie

Make your next move.